These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 18717240

  • 1. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
    Panamonta O, Sumethkul V, Radinahmed P, Laopaiboon M, Kirdpon W.
    J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
    Cin MO, Gursoy A, Morris Y, Aydintug OT, Kamel N, Gullu S.
    Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
    [Abstract] [Full Text] [Related]

  • 3. Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
    Gao Y, Chen M, Ye H, Guo XH, Zhao MH, Wang HY.
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):543-7. PubMed ID: 17371473
    [Abstract] [Full Text] [Related]

  • 4. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.
    Noh JY, Asari T, Hamada N, Makino F, Ishikawa N, Abe Y, Ito K, Ito K.
    Clin Endocrinol (Oxf); 2001 May; 54(5):651-4. PubMed ID: 11380496
    [Abstract] [Full Text] [Related]

  • 5. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H, Hattori M, Fujieda M, Sugihara S, Inomata H, Hoshi M, Miyamoto S.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [Abstract] [Full Text] [Related]

  • 6. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
    Li MT, Zeng XJ, Fang WG, Li H, Li XM, Feng K, Li YZ, Zeng XF, Zhang FC, Tang FL.
    Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2082-5. PubMed ID: 15730621
    [Abstract] [Full Text] [Related]

  • 7. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
    Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W, Chuansumrit A, Chunharas A.
    J Med Assoc Thai; 2002 Nov 17; 85 Suppl 4():S1295-301. PubMed ID: 12549809
    [Abstract] [Full Text] [Related]

  • 8. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
    Guo XH, Zhao MH, Gao Y, Wang SF, Gao Y.
    Zhonghua Yi Xue Za Zhi; 2003 Jun 10; 83(11):932-5. PubMed ID: 12899790
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
    Gao Y, Ye H, Yu F, Guo XH, Zhao MH.
    Clin Immunol; 2005 Oct 10; 117(1):87-93. PubMed ID: 16019262
    [Abstract] [Full Text] [Related]

  • 13. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, Tominaga T, Ejima E, Yokoyama N, Eguchi K.
    Thyroid; 2000 Jul 10; 10(7):595-9. PubMed ID: 10958312
    [Abstract] [Full Text] [Related]

  • 14. [Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].
    Ye H, Gao Y, Guo XH, Zhao MH.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 14; 85(47):3323-7. PubMed ID: 16409836
    [Abstract] [Full Text] [Related]

  • 15. [MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy].
    Fujii A, Arimura Y, Minoshima S, Kobayashi M, Yoshihara K, Tanaka U, Nakabayashi K, Kitamoto K, Nagasawa T, Takahashi H.
    Ryumachi; 1997 Dec 14; 37(6):788-93. PubMed ID: 9492566
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
    Ishii R, Imaizumi M, Ide A, Sera N, Ueki I, Horie I, Ando T, Usa T, Ejima E, Ashizawa K, Eguchi K.
    Endocr J; 2010 Dec 14; 57(1):73-9. PubMed ID: 19851036
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
    Yang J, Yao LP, Dong MJ, Xu Q, Zhang J, Weng WW, Chen F.
    Thyroid; 2017 Dec 14; 27(12):1469-1474. PubMed ID: 29088997
    [Abstract] [Full Text] [Related]

  • 20. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN, Hsu TC, Chou HH, Tsay GJ.
    J Formos Med Assoc; 2004 Apr 14; 103(4):274-9. PubMed ID: 15175822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.